SINOVAC BIOTECH LTD's ticker is SVA and the CUSIP is P8696W104. A total of 52 filers reported holding SINOVAC BIOTECH LTD in Q1 2014. The put-call ratio across all filers is 1.04 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $76,000 | -81.4% | 10,195 | -82.4% | 0.00% | -100.0% |
| Q3 2017 | $409,000 | -7.5% | 58,083 | -11.3% | 0.00% | 0.0% |
| Q2 2017 | $442,000 | +38.1% | 65,447 | +17.2% | 0.00% | 0.0% |
| Q1 2017 | $320,000 | +290.2% | 55,852 | +287.9% | 0.00% | – |
| Q4 2015 | $82,000 | -43.4% | 14,400 | -49.5% | 0.00% | – |
| Q3 2015 | $145,000 | -12.7% | 28,500 | -10.1% | 0.00% | – |
| Q4 2014 | $166,000 | -16.6% | 31,700 | -23.4% | 0.00% | -100.0% |
| Q3 2014 | $199,000 | -57.9% | 41,408 | -50.7% | 0.00% | 0.0% |
| Q2 2014 | $473,000 | -38.6% | 83,934 | -21.5% | 0.00% | -50.0% |
| Q1 2014 | $770,000 | +335.0% | 106,953 | +262.1% | 0.00% | +100.0% |
| Q3 2013 | $177,000 | +60.9% | 29,539 | +5.5% | 0.00% | – |
| Q2 2013 | $110,000 | – | 27,998 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 2,718,735 | $340,000,000 | 7.22% |
| Vivo Capital, LLC | 5,900,000 | $38,173,000 | 4.18% |
| Neumann Advisory Hong Kong Ltd | 315,586 | $2,042 | 0.82% |
| Financial Gravity Asset Management, Inc. | 988 | $3,197,686 | 0.04% |
| Yorktown Management & Research Co Inc | 149,786 | $4,494 | 0.01% |
| Renaissance Technologies | 2,375,841 | $1,537 | 0.00% |
| WELLS FARGO & COMPANY/MN | 1,661 | $10,747 | 0.00% |
| NORTHERN TRUST CORP | 13,787 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 412 | $2,666 | 0.00% |